Bright Minds Biosciences DRUG
NASDAQ DRUG
$50.69 +1.48 (+3.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) Change in Account Payables (2019)

Updated

Bright Minds Biosciences (DRUG) posted Change in Account Payables of $1.21 million for FY2025 (year ended Sep 30, 2025), up 579.3% from $177,913 in FY2024.

Analysis

Bright Minds Biosciences (DRUG) Change in Account Payables (2019) Analysis & Trends

Since FY2020, Bright Minds Biosciences has reported Change in Account Payables for 6 fiscal years.

  • Annual Change in Account Payables shows a five-year compound annual growth rate of 71.7% (FY2020 to FY2025).
  • The FY2025 figure stands as the highest annual Change in Account Payables in data going back to FY2020.
  • Business Quant data shows DRUG's Change in Account Payables at $177,913 in FY2024, -$887,990 in FY2023, $600,014 in FY2022 (+49.8%) and $400,483 in FY2021 (+394.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 18.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Bright Minds Biosciences 387.06 Mn 387.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 27,811.02
API Access

Bright Minds Biosciences Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=DRUG&period=max&api_key=YOUR_API_KEY